Fidelity National Information Servcs Inc (FIS) Stock Price Today
Aura AI Summary
Key Stats
- $20.91BMarket Cap
- -Volume
- TechnologySector
- $69.8152W High
- $37.7252W Low
- -Typical Hold Time
- $41.42BEnterprise Value
- 4.34%Div Yield
- -Trading Activity
Track Fidelity National Information Servcs Inc (FIS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Fidelity National Information Servcs Inc has traded between a low of $37.72 and a high of $69.81, highlighting its annual price range. Buy and sell Fidelity National Information Servcs Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Fidelity National Information Servcs Inc
Fidelity National Information Services' legacy operations provide core and payment processing services to banks, but its business has expanded over time. By acquiring Sungard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS now provides payment processing services for merchants and holds leading positions in the United States and United Kingdom. About a fourth of revenue is generated outside North America.
Most Recent News
Datadog CEO sells 47,054 shares worth $11.1M in a major stock transaction
Datadog CEO Olivier Pomel sold 47,054 shares of the company's stock, totaling $11.1 million. This significant sale could indicate personal financial planning or portfolio rebalancing. Investors may watch for any further insider transactions or compan...

Nexa Resources acquisition by Boliden faces legal review over board's shareholder duties.
Boliden AB plans to acquire Nexa Resources S.A. for $1.3 billion, boosting Nexa's stock target to $15.00 by Scotiabank, signaling a 10.38% potential gain. However, the deal is under legal scrutiny by Halper Sadeh LLC, which is investigating whether N...

Jury finds Parse Biosciences willfully infringed patents, awarding 10x Genomics $4.8M in damages.
A U.S. jury ruled that Parse Biosciences, now part of Qiagen, willfully infringed three patents licensed exclusively to Scale Biosciences, a 10x Genomics subsidiary. The patents, originally from Roche Sequencing Solutions, were upheld as valid and en...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.